In vitro activity of the novel indoloquinone EO-9 and the influence of pH on cytotoxicity.

The novel indoloquinone compound EO-9 is shortly to undergo phase I clinical evaluation as a potential bioreductive drug. Preclinical studies have shown that EO-9 has greater activity against cells derived from human solid tumours than leukaemias in vitro. The results of this study extend the precli...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Phillips, R. M., Hulbert, P. B., Bibby, M. C., Sleigh, N. R., Double, J. A.
Médium: Artigo
Jazyk:Inglês
Vydáno: Nature Publishing Group 1992
Témata:
Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC1977599/
https://ncbi.nlm.nih.gov/pubmed/1558788
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky